Experimental tooth movement-induced osteoclast activation is regulated by sympathetic signaling

Bone

Volumn 52, Issue 1, 2013, Pages 39-47

  Kondo, Mayo ^a   Kondo, Hisataka ^a   Miyazawa, Ken ^a   Goto, Shigemi ^a   Togari, Akifumi ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Experimental tooth movement; Mechano adaptive response; Sympathetic nervous system

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; ISOPRENALINE; NEUROPEPTIDE Y; OXIDOPAMINE; PROPRANOLOL; TYROSINE 3 MONOOXYGENASE;

ALVEOLAR BONE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE REMODELING; CELL COUNT; CHEMICAL SYMPATHECTOMY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENTAL PROCEDURE; EXPERIMENTAL TOOTH MOVEMENT; IMMUNOREACTIVITY; MALE; MOLAR TOOTH; MOUSE; NERVE FIBER; NERVE STIMULATION; NONHUMAN; OSTEOCLAST; OSTEOCLAST ACTIVITY; PERIODONTAL LIGAMENT; REGULATORY MECHANISM; SENSORY NERVE; SYMPATHETIC FUNCTION;

ANIMALS; MICE; MICE, INBRED C57BL; OSTEOCLASTS; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM; TOOTH MOVEMENT;

EID: 84867004405     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.09.007     Document Type: Article

References (56)

1. Ehrlich P.J., Lanyon L.E. Mechanical strain and bone cell function: a review. Osteoporos Int 2002, 13:688-700.
2. Bikle D.D., Sakata T., Halloran B.P. The impact of skeletal unloading on bone formation, Gravit Space. Biol Bull 2003, 16:45-54.
3. Hino K., Nifuji A., Morinobu M., Tsuji K., Ezura Y., Nakashima K., et al. Unloading-induced bone loss was suppressed in gold-thioglucose treated mice. J Cell Biochem 2006, 99:845-852.
4. Kondo H., Nifuji A., Takeda S., Ezura Y., Rittling S.R., Denhardt D.T., et al. Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system. J Biol Chem 2005, 280:30192-30200.
5. Marenzana M., Chenu C. Sympathetic nervous system and bone adaptive response to its mechanical environment. J Musculoskelet Neuronal Interact 2008, 8:111-120.
6. Lanyon L., Skerry T. Postmenopausal osteoporosis as a failure of bone's adaptation to functional loading: a hypothesis. J Bone Miner Res 2001, 16:1937-1947.
7. Kondo H., Ezura Y., Nakamoto T., Hayata T., Notomi T., Sorimachi H., et al. MURF1 deficiency suppresses unloading-induced effects on osteoblasts and osteoclasts to lead to bone loss. J Cell Biochem 2011, 112:3525-3530.
8. Ishijima M., Tsuji K., Rittling S.R., Yamashita T., Kurosawa H., Denhardt D.T., et al. Resistance to unloading-induced three-dimensional bone loss in osteopontin-deficient mice. J Bone Miner Res 2002, 17:661-667.
9. Kato J., Wakisaka S., Kurisu K. Immunohistochemical changes in the distribution of nerve fibers in the periodontal ligament during an experimental tooth movement of the rat molar. Acta Anat (Basel) 1996, 157:53-62.
10. Norevall L.I., Forsgren S., Matsson L. Expression of neuropeptides (CGRP, substance P) during and after orthodontic tooth movement in the rat. Eur J Orthod 1995, 17:311-325.
11. Saito I., Ishii K., Hanada K., Sato O., Maeda T. Responses of calcitonin gene-related peptide-immunopositive nerve fibres in the periodontal ligament of rat molars to experimental tooth movement. Arch Oral Biol 1991, 36:689-692.
12. Vandevska-Radunovic V., Kvinnsland S., Kvinnsland I.H. Effect of experimental tooth movement on nerve fibres immunoreactive to calcitonin gene-related peptide, protein gene product 9.5, and blood vessel density and distribution in rats. Eur J Orthod 1997, 19:517-529.
13. Brown D.F., Moerenhout R.G. The pain experience and psychological adjustment to orthodontic treatment of preadolescents, adolescents, and adults. Am J Orthod Dentofacial Orthop 1991, 100:349-356.
14. Deguchi T., Yabuuchi T., Ando R., Ichikawa H., Sugimoto T., Takano-Yamamoto T. Increase of galanin in trigeminal ganglion during tooth movement. J Dent Res 2006, 85:658-663.
15. Rygh P. Ultrastructural cellular reactions in pressure zones of rat molar periodontium incident to orthodontic tooth movement. Acta Odontol Scand 1972, 30:575-593.
16. Yokoya K., Sasaki T., Shibasaki Y. Distributional changes of osteoclasts and pre-osteoclastic cells in periodontal tissues during experimental tooth movement as revealed by quantitative immunohistochemistry of H(+)-ATPase. J Dent Res 1997, 76:580-587.
17. Yamashiro T., Fujiyama K., Fujiyoshi Y., Inaguma N., Takano-Yamamoto T. Inferior alveolar nerve transection inhibits increase in osteoclast appearance during experimental tooth movement. Bone 2000, 26:663-669.
18. Takeda S., Karsenty G. Central control of bone formation. J Bone Miner Metab 2001, 19:195-198.
19. Takeuchi T., Tsuboi T., Arai M., Togari A. Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells. Biochem Pharmacol 2001, 61:579-586.
20. Togari A., Arai M., Mizutani S., Mizutani S., Koshihara Y., Nagatsu T. Expression of mRNAs for neuropeptide receptors and beta-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells. Neurosci Lett 1997, 233:125-128.
21. Noda M., Nagao M., Hanyu R., Mizoguchi F., Notomi T., Hayata T., et al. Control of bone remodeling by nervous system. Nervous system and bone. Clin Calcium 2010, 20:1801-1805.
22. Bonnet N., Benhamou C.L., Brunet-Imbault B., Arlettaz A., Horcajada M.N., Richard O., et al. Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats. Bone 2005, 37:622-633.
23. Bonnet N., Brunet-Imbault B., Arlettaz A., Horcajada M.N., Collomp K., Benhamou C.L., et al. Alteration of trabecular bone under chronic beta2 agonists treatment. Med Sci Sports Exerc 2005, 37:1493-1501.
24. Ducy P., Amling M., Takeda S., Priemel M., Schilling A.F., Beil F.T., et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000, 197-207.
25. Hino K., Nifuji A., Morinobu M., Tsuji K., Ezura Y., Nakashima K., et al. Unloading-induced bone loss was suppressed in gold-thioglucose treated mice. J Cell Biochem 2006, 99:845-852.
26. Elefteriou F., Ahn J.D., Takeda S., Starbuck M., Yang X., Liu X., et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005, 434:514-520.
27. Togari A. Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc Res Tech 2002, 58:77-84.
28. Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K.L., et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 2002, 111:305-317.
29. Marenzana M., De Souza R.L., Chenu C. Blockade of beta-adrenergic signaling does not influence the bone mechano-adaptive response in mice. Bone 2007, 41:206-215.
30. Kondo A., Togari A. In vivo stimulation of sympathetic nervous system modulates osteoblastic activity in mouse calvaria. Am J Physiol Endocrinol Metab 2003, 285:E661-E667.
31. Williams J.M., Peterson R.G., Shea P.A., Schmedtje J.F., Bauer D.C., Felten D.L. Sympathetic innervation of murine thymus and spleen: evidence for a functional link between the nervous and immune systems. Brain Res Bull 1981, 6:83-94.
32. de Champlain J. Degeneration and regrowth of adrenergic nerve fibers in the rat peripheral tissues after 6-hydroxydopamine. Can J Physiol Pharmacol 1971, 49:345-355.
33. Waldo C.M., Rothblatt J.M. Histologic response to tooth movement in the laboratory rat; procedure and preliminary observations. J Dent Res 1954, 33:481-486.
34. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. report of the ASBMR histomorphometry nomenclature committee. J Bone Miner Res 1987, 2:595-610.
35. Flach A.J., Peterson J.S., Roizen M.F., Wood I.S. Ptosis in the rat following topically administered 2% epinephrine. Invest Ophthalmol Vis Sci 1983, 24:766-771.
36. Purpura P., Westman L., Will P., Eidelman A., Kagan V.E., Osipov A.N., et al. Adjunctive treatment of murine neuroblastoma with 6-hydroxydopamine and tempol. Cancer Res 1996, 56:2336-2342.
37. Kondo H., Togari A. Continuous treatment with a low-dose beta-agonist reduces bone mass by increasing bone resorption without suppressing bone formation. Calcif Tissue Int 2011, 88:23-32.
38. Nagao M., Feinstein T.N., Ezura Y., Hayata T., Notomi T., Saita Y., et al. Sympathetic control of bone mass regulated by osteopontin. Proc Natl Acad Sci U S A 2011, 108:17767-17772.
39. Rygh P. Ultrastructural changes in pressure zones of human periodontium incident to orthodontic tooth movement. Acta Odontol Scand 1973, 31:109-122.
40. Takano-Yamamoto T., Kawakami M., Kobayashi Y., Yamashiro T., Sakuda M. The effect of local application of 1,25-dihydroxycholecalciferol on osteoclast numbers in orthodontically treated rats. J Dent Res 1992, 71:53-59.
41. Kvinnsland I., Kvinnsland S. Changes in CGRP-immunoreactive nerve fibres during experimental tooth movement in rats. Eur J Orthod 1990, 12:320-329.
42. Vandevska-Radunovic V., Kvinnsland S., Kvinnsland I.H. Effect of experimental tooth movement on nerve fibres immunoreactive to calcitonin gene-related peptide, protein gene product 9.5, and blood vessel density and distribution in rats. Eur J Orthod 1997, 19:517-529.
43. Cridland R.A., Henry J.L. Effects of intrathecal administration of neuropeptides on a spinal nociceptive reflex in the rat: VIP, galanin, CGRP, TRH, somatostatin and angiotensin II. Neuropeptides 1988, 11:23-32.
44. Ryu P.D., Murase K., Gerber G., Randic M. Actions of calcitonin gene-related peptide on rat sensory ganglion neurones. Physiol Bohemoslov 1988, 37:259-265.
45. sseur R., Sabatier J.P., Potrel-Burgot C., Lecoq B., Creveuil C., Marcelli C. Sympathetic nervous system as transmitter of mechanical loading in bone. Joint Bone Spine 2003, 70:515-519.
46. Bataille C., Mauprivez C., Hay E., Baroukh B., Brun A., Chaussain C., et al. Different sympathetic pathways control the metabolism of distinct bone envelopes. Bone 2012, 50:1162-1172.
47. Arai M., Nagasawa T., Koshihara Y., Yamamoto S., Togari A. Effects of beta-adrenergic agonists on bone-resorbing activity in human osteoclast-like cells. Biochim Biophys Acta 2003, 1640:137-142.
48. Zhang P., Tanaka S.M., Jiang H., Su M., Yokota H. Diaphyseal bone formation in murine tibiae in response to knee loading. J Appl Physiol 2006, 100:1452-1459.
49. de Souza R.L., Pitsillides A.A., Lanyon L.E., Skerry T.M., Chenu C. Sympathetic nervous system does not mediate the load-induced cortical new bone formation. J Bone Miner Res 2005, 20:2159-2168.
50. Tran Van P.T., Vignery A., Baron R. Cellular kinetics of the bone remodeling sequence in the rat. Anat Rec 1982, 202:445-451.
51. Dietrich J.W., Mundy G.R., Raisz L.G. Inhibition of bone resorption in tissue culture by membrane-stabilizing drugs. Endocrinology 1979, 104:1644-1648.
52. Serre C.M., Farlay D., Delmas P.D., Chenu C. Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers. Bone 1999, 25:623-629.
53. Wada S., Kojo T., Wang Y.H., Ando H., Nakanishi E., Zhang M., et al. Effect of loading on the development of nerve fibers around oral implants in the dog mandible. Clin Oral Implants Res 2001, 12:219-224.
54. Bjurholm A. Neuroendocrine peptides in bone. Int Orthop 1991, 15:325-329.
55. Amano S., Arai M., Goto S., Togari A. Inhibitory effect of NPY on isoprenaline-induced osteoclastogenesis in mouse bone marrow cells. Biochim Biophys Acta 2007, 1770:966-973.
56. Ishizuka K., Hirukawa K., Nakamura H., Togari A. Inhibitory effect of CGRP on osteoclast formation by mouse bone marrow cells treated with isoproterenol. Neurosci Lett 2005, 379:47-51.